• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 感染威胁肠道健康:潜在机制和治疗策略综述。

SARS-CoV-2 infection threatening intestinal health: A review of potential mechanisms and treatment strategies.

机构信息

State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, China.

出版信息

Crit Rev Food Sci Nutr. 2023 Nov;63(33):12578-12596. doi: 10.1080/10408398.2022.2103090. Epub 2022 Jul 27.

DOI:10.1080/10408398.2022.2103090
PMID:35894645
Abstract

The outbreak of the COVID-19 pandemic has brought great problems to mankind, including economic recession and poor health. COVID-19 patients are frequently reported with gastrointestinal symptoms such as diarrhea and vomiting in clinical diagnosis. Maintaining intestinal health is the key guarantee to maintain the normal function of multiple organs, otherwise it will be a disaster. Therefore, the purpose of this review was deeply understanded the potential mechanism of SARS-CoV-2 infection threatening intestinal health and put forward reasonable treatment strategies. Combined with the existing researches, we summarized the mechanism of SARS-CoV-2 infection threatening intestinal health, including intestinal microbiome disruption, intestinal barrier dysfunction, intestinal oxidative stress and intestinal cytokine storm. These adverse intestinal events may affect other organs through the circulatory system or aggravate the course of the disease. Typically, intestinal disadvantage may promote the progression of SARS-CoV-2 through the gut-lung axis and increase the disease degree of COVID-19 patients. In view of the lack of specific drugs to inhibit SARS-CoV-2 replication, the current review described new strategies of probiotics, prebiotics, postbiotics and nutrients to combat SARS-CoV-2 infection and maintain intestinal health. To provide new insights for the prevention and treatment of gastrointestinal symptoms and pneumonia in patients with COVID-19.

摘要

新型冠状病毒肺炎(COVID-19)疫情的爆发给人类带来了巨大的问题,包括经济衰退和健康状况不佳。在临床诊断中,经常有 COVID-19 患者报告出现腹泻和呕吐等胃肠道症状。维护肠道健康是维持多个器官正常功能的关键保障,否则将是一场灾难。因此,本综述的目的是深入了解 SARS-CoV-2 感染威胁肠道健康的潜在机制,并提出合理的治疗策略。结合现有研究,我们总结了 SARS-CoV-2 感染威胁肠道健康的机制,包括肠道微生物失调、肠道屏障功能障碍、肠道氧化应激和肠道细胞因子风暴。这些不良的肠道事件可能通过循环系统影响其他器官,或加重疾病进程。通常情况下,肠道不利因素可能通过肠-肺轴促进 SARS-CoV-2 的进展,并增加 COVID-19 患者的疾病严重程度。鉴于缺乏特异性抑制 SARS-CoV-2 复制的药物,本综述描述了益生菌、益生元、后生元和营养素等新策略,以对抗 SARS-CoV-2 感染并维持肠道健康。为预防和治疗 COVID-19 患者的胃肠道症状和肺炎提供新的思路。

相似文献

1
SARS-CoV-2 infection threatening intestinal health: A review of potential mechanisms and treatment strategies.SARS-CoV-2 感染威胁肠道健康:潜在机制和治疗策略综述。
Crit Rev Food Sci Nutr. 2023 Nov;63(33):12578-12596. doi: 10.1080/10408398.2022.2103090. Epub 2022 Jul 27.
2
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome.与 COVID-19 相关的胃肠道症状:对肠道微生物组的影响。
Transl Res. 2020 Dec;226:57-69. doi: 10.1016/j.trsl.2020.08.004. Epub 2020 Aug 20.
3
Coronavirus disease-2019 and the intestinal tract: An overview.新型冠状病毒病 2019 与肠道:概述。
World J Gastroenterol. 2021 Apr 7;27(13):1255-1266. doi: 10.3748/wjg.v27.i13.1255.
4
Gastrointestinal Involvement in SARS-CoV-2 Infection.新型冠状病毒感染的胃肠道表现。
Viruses. 2022 May 30;14(6):1188. doi: 10.3390/v14061188.
5
Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review.在 SARS-CoV-2 大流行期间用于肠道微生物组生物矫正的当前药物靶点:系统评价。
Curr Drug Targets. 2022;23(11):1099-1125. doi: 10.2174/1389450123666220418094853.
6
Postbiotics as potential promising tools for SARS-CoV-2 disease adjuvant therapy.后生元作为 SARS-CoV-2 疾病佐剂治疗的有前途的潜在工具。
J Appl Microbiol. 2022 Jun;132(6):4097-4111. doi: 10.1111/jam.15457. Epub 2022 Mar 1.
7
Precision Postbiotics and Mental Health: the Management of Post-COVID-19 Complications.精准后生元和心理健康:管理新冠后并发症。
Probiotics Antimicrob Proteins. 2022 Jun;14(3):426-448. doi: 10.1007/s12602-021-09875-4. Epub 2021 Nov 22.
8
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.2019 年冠状病毒病中肠道微生物组的改变及其治疗潜力。
World J Gastroenterol. 2022 Dec 21;28(47):6689-6701. doi: 10.3748/wjg.v28.i47.6689.
9
SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.SARS-CoV-2 微生物失调相关疾病及可能的益生菌作用。
Biomed Pharmacother. 2021 Jan;133:110947. doi: 10.1016/j.biopha.2020.110947. Epub 2020 Nov 11.
10
Autoimmunity and COVID-19 - The microbiotal connection.自身免疫与 COVID-19:微生物组的关联。
Autoimmun Rev. 2021 Aug;20(8):102865. doi: 10.1016/j.autrev.2021.102865. Epub 2021 Jun 10.

引用本文的文献

1
The intricate interactions between the lungs and gut in patients: unraveling the crosstalk mechanism.患者肺部与肠道之间的复杂相互作用:揭示其串扰机制。
Front Med (Lausanne). 2025 Jul 30;12:1624907. doi: 10.3389/fmed.2025.1624907. eCollection 2025.
2
ACE2 mediates tryptophan alleviation on diarrhea by repairing intestine barrier involved mTOR pathway.ACE2 通过修复涉及 mTOR 途径的肠屏障来介导色氨酸缓解腹泻。
Cell Mol Biol Lett. 2024 Jun 14;29(1):90. doi: 10.1186/s11658-024-00603-8.
3
Alterations in microbiota of patients with COVID-19: implications for therapeutic interventions.
新型冠状病毒肺炎患者微生物群的改变:对治疗干预的启示
MedComm (2020). 2024 Mar 15;5(4):e513. doi: 10.1002/mco2.513. eCollection 2024 Apr.
4
The lung-gut crosstalk in respiratory and inflammatory bowel disease.肺-肠互作在呼吸和炎症性肠病中的作用。
Front Cell Infect Microbiol. 2023 Aug 23;13:1218565. doi: 10.3389/fcimb.2023.1218565. eCollection 2023.
5
Trajectory of Gastrointestinal Symptoms in Previously Hospitalized COVID-19 Survivors: The Long COVID Experience Multicenter Study.COVID-19 幸存者住院后胃肠道症状的轨迹:长新冠多中心研究。
Viruses. 2023 May 10;15(5):1134. doi: 10.3390/v15051134.
6
Gut microbiota in COVID-19: new insights from inside.肠道微生物组在 COVID-19 中的作用:来自内部的新见解。
Gut Microbes. 2023 Jan-Dec;15(1):2201157. doi: 10.1080/19490976.2023.2201157.
7
Tryptophan Metabolism 'Hub' Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease.色氨酸代谢“枢纽”基因表达与 COVID-19 感染和炎症性肠病中的炎症增加和严重疾病结局相关。
Int J Mol Sci. 2022 Nov 26;23(23):14776. doi: 10.3390/ijms232314776.